Clover Health Investments, Corp.
CLOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,543,559 | $459,080 | $442,669 | $1,751,571 |
| - Cash | $194,543 | $122,863 | $103,791 | $299,968 |
| + Debt | $0 | $4,663 | $5,860 | $27,827 |
| Enterprise Value | $1,349,016 | $340,880 | $344,738 | $1,479,430 |
| Revenue | $1,371,131 | $1,260,543 | $1,096,552 | $1,471,996 |
| % Growth | 8.8% | 15% | -25.5% | – |
| Gross Profit | $364,804 | $255,953 | $103,479 | -$79,182 |
| % Margin | 26.6% | 20.3% | 9.4% | -5.4% |
| EBITDA | -$44,935 | -$207,632 | -$252,034 | -$569,600 |
| % Margin | -3.3% | -16.5% | -23% | -38.7% |
| Net Income | -$43,009 | -$213,361 | -$339,567 | -$587,756 |
| % Margin | -3.1% | -16.9% | -31% | -39.9% |
| EPS Diluted | -0.088 | -0.45 | -0.71 | -1.25 |
| % Growth | 80.5% | 36.6% | 43.2% | – |
| Operating Cash Flow | $34,845 | -$115,871 | -$203,926 | -$282,326 |
| Capital Expenditures | -$1,556 | -$584 | -$4,467 | -$723 |
| Free Cash Flow | $33,289 | -$116,455 | -$208,393 | -$283,049 |